John Naybour
CEO
Eventum Orthopaedics
Eventum Orthopaedics has developed Quadsense, a device that provides real-time intraoperative measurements of the patellofemoral joint during total knee replacement surgeries. This technology enables surgeons to make informed decisions regarding kneecap positioning, addressing the significant issue of patient dissatisfaction, which affects up to 20% of knee replacement outcomes.
- Hardware
- Healthcare Technology
- Medical Devices
Updated 7 months ago
Funding
Raised to date
$4.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Up to 20% of patients undergoing total knee replacement (TKR) experience dissatisfaction, often due to issues with kneecap positioning and function. Current surgical techniques lack real-time, intraoperative data to optimize patellofemoral joint mechanics during TKR. This can lead to anterior knee pain and reduced patient satisfaction.
Solution
Eventum Orthopaedics' Quadsense is an intraoperative measurement device that provides surgeons with real-time data on the patellofemoral joint during total knee replacement procedures. The device allows surgeons to make informed decisions regarding kneecap positioning, addressing a key factor contributing to patient dissatisfaction. Quadsense is designed as a comparative tool, providing information on the effect of resurfacing the femur and tibia on the force through the patellofemoral joint. By providing objective data, Quadsense aims to improve the biomechanics of the knee joint and enhance patient outcomes following TKR.
Target Audience
The primary target audience includes orthopedic surgeons specializing in total knee replacement procedures.
Features
- Real-time, intraoperative measurement of patellofemoral joint forces
- Comparative data on the impact of femoral and tibial resurfacing
- Designed to integrate into existing surgical workflows and with any implant
- Developed with input from global key opinion leader (KOL) surgeons